Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS)
CUSIP: 00461U105
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, $0.00001 par value per share
- Shares outstanding
- 121,058,810
- Total 13F shares
- 56,004,936
- Share change
- +10,561,143
- Total reported value
- $983,410,407
- Put/Call ratio
- 74%
- Price per share
- $17.56
- Number of holders
- 128
- Value change
- +$20,628,850
- Number of buys
- 81
- Number of sells
- 49
Quarterly Holders Quick Answers
What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00461U105:
Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Dorsey Wright & Associates |
13F
|
Company |
0.01%
|
6,110
|
$153,972,000 | — | 31 Mar 2021 | |
| VR Adviser, LLC |
13F
|
Company |
3.1%
|
3,720,582
|
$93,759,000 | — | 31 Mar 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2.9%
|
3,569,192
|
$89,944,000 | — | 31 Mar 2021 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
2.8%
|
3,399,034
|
$85,656,000 | — | 31 Mar 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.6%
|
3,200,000
|
$80,640,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.5%
|
2,986,478
|
$75,259,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
2,117,852
|
$53,370,000 | — | 31 Mar 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.7%
|
2,000,000
|
$50,400,000 | — | 31 Mar 2021 | |
| Foresite Capital Management III, LLC |
13F
|
Company |
1.6%
|
1,954,904
|
$49,264,000 | — | 31 Mar 2021 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.4%
|
1,709,136
|
$43,070,000 | — | 31 Mar 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
1.4%
|
1,647,214
|
$41,510,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
1.2%
|
1,500,974
|
$37,825,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
1,327,349
|
$33,449,000 | — | 31 Mar 2021 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
1%
|
1,258,243
|
$31,708,000 | — | 31 Mar 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.85%
|
1,028,084
|
$25,908,000 | — | 31 Mar 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.84%
|
1,022,612
|
$25,770,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.81%
|
984,876
|
$24,819,000 | — | 31 Mar 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.75%
|
907,034
|
$22,857,000 | — | 31 Mar 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.69%
|
831,329
|
$20,950,000 | — | 31 Mar 2021 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
0.57%
|
696,000
|
$17,539,000 | — | 31 Mar 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.54%
|
650,000
|
$16,380,000 | — | 31 Mar 2021 | |
| Aisling Capital Management LP |
13F
|
Company |
0.52%
|
634,455
|
$15,988,000 | — | 31 Mar 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.5%
|
600,000
|
$15,120,000 | — | 31 Mar 2021 | |
| Holocene Advisors, LP |
13F
|
Company |
0.43%
|
525,863
|
$13,252,000 | — | 31 Mar 2021 | |
| Endurant Capital Management LP |
13F
|
Company |
0.38%
|
455,385
|
$11,476,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.37%
|
447,635
|
$11,280,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
376,864
|
$9,496,000 | — | 31 Mar 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.3%
|
367,392
|
$9,258,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.28%
|
343,247
|
$8,650,000 | — | 31 Mar 2021 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
336,737
|
$8,486,000 | — | 31 Mar 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.27%
|
327,800
|
$8,261,000 | — | 31 Mar 2021 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.26%
|
317,730
|
$8,007,000 | — | 31 Mar 2021 | |
| Stenham Asset Management Ltd |
13F
|
Company |
0.23%
|
283,500
|
$7,144,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.21%
|
258,711
|
$6,520,000 | — | 31 Mar 2021 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.2%
|
240,233
|
$6,047,000 | — | 31 Mar 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.18%
|
222,267
|
$5,601,000 | — | 31 Mar 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
214,300
|
$5,400,000 | — | 31 Mar 2021 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.17%
|
205,295
|
$5,173,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.16%
|
192,942
|
$4,862,000 | — | 31 Mar 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.16%
|
188,200
|
$4,742,000 | — | 31 Mar 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.15%
|
175,799
|
$4,430,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.14%
|
174,076
|
$4,387,000 | — | 31 Mar 2021 | |
| Tri Locum Partners LP |
13F
|
Company |
0.14%
|
164,199
|
$4,138,000 | — | 31 Mar 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.13%
|
152,119
|
$3,833,000 | — | 31 Mar 2021 | |
| J. Goldman & Co LP |
13F
|
Company |
0.12%
|
144,987
|
$3,654,000 | — | 31 Mar 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.12%
|
140,855
|
$3,550,000 | — | 31 Mar 2021 | |
| Global IMC LLC |
13F
|
Company |
0.1%
|
121,563
|
$3,063,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
120,582
|
$3,039,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
111,156
|
$2,801,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
108,795
|
$2,741,000 | — | 31 Mar 2021 |
Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) as of Q2 2021
As of 30 Jun 2021,
Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,004,936 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VR Adviser, LLC, Rock Springs Capital Management LP, Foresite Capital Management IV, LLC, BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Cormorant Asset Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., and Foresite Capital Management III, LLC.
This page lists
128
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
95
Q2 2021 holders
128
Holder diff
33
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.